e-learning
resources
Virtual 2020
Pre-Congress Content
Pulmonary hypertension in lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis
D. Santos Ribeiro (Auderghem, Belgium)
Source:
Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session:
Pulmonary hypertension in lung diseases
Session type:
E-poster session
Number:
288
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Santos Ribeiro (Auderghem, Belgium). LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis. 288
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The definition of pulmonary hypertension: history, practical implications and current controversies
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017
LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021
LSC - 2020 - IRF5 regulates airway macrophage metabolic responses to viral challenge
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
LSC - 2020 - The transcriptome of IPF fibrotic foci identifies the fatty acid metabolism as a critical pathway in fibrogenesis
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
rHuKGF optimistically attenuates MAPK/ERK mediated cell proliferation pathway in emphysematous lungs
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD)
Source: ERS Lung Science Conference 2017
Year: 2017
LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
YI02 - Activation of Wnt/beta-catenin signaling promotes lung epithelial repair in emphysema
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
TRIM33 prevents pulmonary fibrosis by impairing TGF-ß1 signalling
Source: Eur Respir J, 55 (6) 1901346; 10.1183/13993003.01346-2019
Year: 2020
LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019
Effect of rHuKGF in vegf dependent cell survival progression in emphysematous condition via akt signalling pathway
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
LSC - 2020 - Glutathione-S-transferase P promotes Interleukin-1ß-induced inflammation and metabolic reprogramming in mice with allergic airways disease
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Insulin resistance exacerbates lung inflammation in obese patients via PI3K/Akt signaling pathway
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
LSC - 2020 - Caspase-1 activation by cigarette smoke occurs via TLR4/TRIF/caspase-8 axis leading to metabolic alterations in human macrophages
Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept